1. Home
  2. FGEN vs CLPS Comparison

FGEN vs CLPS Comparison

Compare FGEN & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • CLPS
  • Stock Information
  • Founded
  • FGEN 1993
  • CLPS 2005
  • Country
  • FGEN United States
  • CLPS Hong Kong
  • Employees
  • FGEN N/A
  • CLPS N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • CLPS Computer Software: Prepackaged Software
  • Sector
  • FGEN Health Care
  • CLPS Technology
  • Exchange
  • FGEN Nasdaq
  • CLPS Nasdaq
  • Market Cap
  • FGEN 34.5M
  • CLPS 35.1M
  • IPO Year
  • FGEN 2014
  • CLPS 2018
  • Fundamental
  • Price
  • FGEN $0.55
  • CLPS $1.33
  • Analyst Decision
  • FGEN
  • CLPS
  • Analyst Count
  • FGEN 0
  • CLPS 0
  • Target Price
  • FGEN N/A
  • CLPS N/A
  • AVG Volume (30 Days)
  • FGEN 753.5K
  • CLPS 23.5K
  • Earning Date
  • FGEN 02-24-2025
  • CLPS 03-04-2025
  • Dividend Yield
  • FGEN N/A
  • CLPS 9.77%
  • EPS Growth
  • FGEN N/A
  • CLPS N/A
  • EPS
  • FGEN N/A
  • CLPS N/A
  • Revenue
  • FGEN $180,015,000.00
  • CLPS $142,812,726.00
  • Revenue This Year
  • FGEN $21.91
  • CLPS N/A
  • Revenue Next Year
  • FGEN N/A
  • CLPS N/A
  • P/E Ratio
  • FGEN N/A
  • CLPS N/A
  • Revenue Growth
  • FGEN 16.15
  • CLPS N/A
  • 52 Week Low
  • FGEN $0.18
  • CLPS $0.68
  • 52 Week High
  • FGEN $2.80
  • CLPS $1.70
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 58.51
  • CLPS 62.50
  • Support Level
  • FGEN $0.46
  • CLPS $1.19
  • Resistance Level
  • FGEN $0.51
  • CLPS $1.36
  • Average True Range (ATR)
  • FGEN 0.04
  • CLPS 0.07
  • MACD
  • FGEN 0.00
  • CLPS 0.00
  • Stochastic Oscillator
  • FGEN 72.57
  • CLPS 82.46

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About CLPS CLPS Incorporation

CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.

Share on Social Networks: